Innoviz closes $30M registered share offering

Innoviz Technologies Ltd. closed a registered direct offering of 66,666,667 ordinary shares, generating gross proceeds of approximately $30 million before placement agent fees and other offering expenses.

Rhea-AI Filing Summary

Innoviz Technologies Ltd. closed a registered direct offering of 66,666,667 ordinary shares, generating gross proceeds of approximately $30 million before placement agent fees and other offering expenses. The transaction closed on July 29, 2026.

The company plans to use the net proceeds for general business purposes, including supporting commercialization of Perciz, its dedicated security and defense brand. The shares were issued under a Form F-3 registration statement that was declared effective on August 21, 2025, together with a base prospectus and a July 28, 2026 prospectus supplement, and related legal opinions and consents were filed as exhibits.

Filing Explained

The completed issuance adds 66,666,667 shares, reducing existing holders’ percentage ownership absent offsetting changes.

Innoviz reports that its registered direct offering closed on July 29, 2026, selling 66,666,667 ordinary shares for approximately $30 million in gross proceeds before placement-agent fees and expenses; the added shares reduce existing holders’ percentage ownership absent offsetting changes.

A registered direct offering is a negotiated sale of registered securities to selected investors, and the placement-agent fees reduce the proceeds Innoviz keeps from the stated gross amount.

The gross proceeds equal 295.7 days of the last supplied quarterly operating cash use, a historical comparison rather than a forecast of available funding.

At December 31, 2025, reported cash and equivalents were $8.638 million, alongside $9.466 million of short-term investments.

Sources and calculations

• Innoviz Technologies Ltd. Form 6-K (2026-07-30)
• Dilution definition (undated)
• Registered direct offering definition (undated)
• Innoviz latest supplied quarterly fundamentals (2025Q4)

• Offering gross against the last reported quarterly operating outflow, in days at that rate $30,000,000 / ($9,131,000 / 90) = 295.7 days

Key Figures

Ordinary shares offered: 66,666,667 shares Gross proceeds: approximately $30 million Form F-3 file number: 333-289554 +3 more

6 metrics

Ordinary shares offered 66,666,667 shares Registered direct offering closed on July 29, 2026

Gross proceeds approximately $30 million Before placement agent fees and offering expenses

Form F-3 file number 333-289554 Registration statement used for the offering

Form F-3 effectiveness date August 21, 2025 Date SEC declared the registration statement effective

Prospectus supplement date July 28, 2026 Prospectus supplement used for the offering

Exhibits furnished 5.1 and 23.1 Legal opinion and consent from Naschitz, Brandes, Amir & Co., Advocates

Key Terms

registered direct offering, Form F-3, prospectus supplement, forward-looking statements

4 terms

registered direct offering financial

"closed its previously announced offering of 66,666,667 of the Company’s ordinary shares in a registered direct offering"

A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.

Form F-3 regulatory

"offered by the Company pursuant to a registration statement on Form F-3 (File No. 333-289554)"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

prospectus supplement regulatory

"the base prospectus filed as part of the Registration Statement, and the prospectus supplement dated July 28, 2026"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

forward-looking statements regulatory

"This Report includes forward-looking statements within the meaning of the federal securities laws"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Innoviz Technologies (INVZ) report in the July 2026 Form 6-K?

Innoviz Technologies reported the closing of a registered direct offering of 66,666,667 ordinary shares, providing gross proceeds of approximately $30 million before fees and expenses. The offering was conducted under an effective Form F-3 registration statement and related prospectus documents.

How much capital did Innoviz Technologies (INVZ) raise and what was offered?

Innoviz raised gross proceeds of approximately $30 million by offering 66,666,667 ordinary shares in a registered direct transaction. These proceeds are stated before deducting placement agent fees and other offering expenses payable by the company.

How will Innoviz Technologies (INVZ) use the proceeds from the offering?

Innoviz intends to use the net proceeds for general business purposes, including supporting the commercialization of Perciz, its dedicated security and defense brand. The filing does not limit the proceeds solely to Perciz-related activities.

Under which registration statement was the Innoviz (INVZ) offering conducted?

The ordinary shares were offered under a Form F-3 registration statement, File No. 333-289554, which was declared effective by the SEC on August 21, 2025. A base prospectus and a July 28, 2026 prospectus supplement were used in connection with the sale.

When did Innoviz Technologies (INVZ) close its registered direct offering?

Innoviz closed the registered direct offering on July 29, 2026. On that date, the company completed the sale of 66,666,667 ordinary shares, resulting in gross proceeds of approximately $30 million before fees and expenses associated with the transaction.

Which legal opinions were furnished with the Innoviz (INVZ) Form 6-K?

Innoviz furnished an opinion of Naschitz, Brandes, Amir & Co., Advocates on the validity of the ordinary shares as Exhibit 5.1 and a related consent as Exhibit 23.1, with the consent included within the opinion exhibit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 06:14 AM Accepted by SEC EDGAR 07/30/2026 - 06:13 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission file number: 001-40310

Innoviz Technologies Ltd. 

(Translation of registrant’s name into English)

Innoviz Technologies Campus

5 Uri Ariav Street, Bldg. C

Nitzba 300, Rosh HaAin, Israel

(Address of principal executive offices) 

_____________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

 INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Closing of Registered Direct Offering

On July 29, 2026, Innoviz Technologies Ltd. (the “Company” or “Innoviz”) closed its previously announced offering of 66,666,667 of the Company’s ordinary shares in a registered direct offering for gross proceeds of approximately $30 million, before deducting the placement agent fees and offering expenses payable by the Company. The Company intends to use the net proceeds for general business purposes, including (but not limited to), supporting the commercialization of Perciz, the Company’s dedicated security and defense brand.

The ordinary shares were offered by the Company pursuant to a registration statement on Form F-3 (File No. 333-289554) (the “Registration Statement”), previously declared effective by the Securities and Exchange Commission (the “Commission”) on August 21, 2025, the base prospectus filed as part of the Registration Statement, and the prospectus supplement dated July 28, 2026.

This Report on Form 6-K (this “Report”) shall not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

A copy of the opinion of Naschitz, Brandes, Amir & Co., Advocates relating to the legality of the issuance and sale of the ordinary shares is filed as Exhibit 5.1.

This Report and related exhibits are incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-265170 and 333-289554) and Form S-8 (File Nos. 333-255511, 333-265169, 333-270416, 333-277852, 333-285758 and 333-292573), and shall be a part thereof from the date on which this Report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

Forward-Looking Statements:

This Report includes forward-looking statements within the meaning of the federal securities laws, including statements regarding the intended use of the proceeds from the offering. Forward-looking statements represent Innoviz's current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. Among those risks and uncertainties are market conditions, including the trading price and volatility of Innoviz's securities, risks relating to Innoviz's business and the satisfaction of closing conditions in the securities purchase agreement related to the offering. The forward-looking statements included in this Report speak only as of the date of this Report, and Innoviz does not undertake to update the statements included in this Report for subsequent developments, except as may be required by law.

The Company hereby furnishes the following documents as Exhibits 5.1 and 23.1.

Exhibit No.			Description
5.1				Opinion of Naschitz, Brandes, Amir & Co., Advocates as to the validity of the ordinary shares.
23.1				Consent of Naschitz, Brandes, Amir & Co., Advocates (included in Exhibit 5.1).

 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Innoviz Technologies Ltd.
	By:	/s/ Eldar Cegla
		Name: Eldar Cegla
		Title: Chief Financial Officer

Date: July 30, 2026

Filing Exhibits & Attachments

1 document

Other Documents

• EX-5.1 EXHIBIT 5.1 6.8 KB